our medicinesSave Lives
Ventria Bioscience’s internal therapeutic pipeline is focused on safely improving clinical outcomes in infectious disease and inflammatory disease.
the VentriaTEAM
Our people and our company are driven by the scientific method and by our vision of improving longevity and quality of life for people all over the globe.
Every day, our talented scientists, entrepreneurs, and advisors work together with a sense of urgency and commitment.
Our Research Partners
Our Blog: In Context
Ventria Bioscience wins exclusion order against infringing and mislabled products from Wuhan Healthgen
Ventria’s success in excluding unfairly traded imports secures its ability to continue to invest in the next generation of plant biotechnology innovation Junction City, Kansas – September 14th, 2022 – Ventria Bioscience Inc. (Ventria) today announced that the United States International Trade Commission (ITC) completed its review of Administrative Law Judge McNamara’s previous determination and affirmed the […]